
    
      This phase II clinical study will examine the outcomes of surgical therapy for patients with
      both intra- and extra-hepatic CRC metastases.

      The treatment protocol includes surgical resection of metastases from Colorectal cancer.
      Multi-modality co-interventions such as chemotherapy (neo-adjuvant, or post-operative),
      radiofrequency ablation (RFA) and/or portal vein embolization (PVE) will be permitted.

      The eligibility criteria include: patients with both intra-hepatic and extra-hepatic
      metastases from colorectal cancer, the number of extra-hepatic metastases must be three or
      less on pre-operative imaging, all metastatic deposits must be resectable with R0 intent,
      there must be no contra-indications to major surgery and an ECOG performance status of 0, 1
      or 2.
    
  